Bg pattern

MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Miglustat Gen.Orph 100 mg hard capsules EFG

miglustat

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

  1. What is Miglustat Gen.Orph and what is it used for.
  2. What you need to know before you take Miglustat Gen.Orph.
  3. How to take Miglustat Gen.Orph.
  4. Possible side effects.
  5. Storing Miglustat Gen.Orph.
  6. Contents of the pack and other information.

1. What is Miglustat Gen.Orph and what is it used for

Miglustat Gen.Orph contains the active substance miglustat, which belongs to a group of medicines that have an effect on metabolism. It is used to treat two disorders:

  • Miglustat Gen.Orph is used to treat mild to moderate type 1 Gaucher disease in adults.

In type 1 Gaucher disease, your body cannot break down a substance called glucosylceramide. As a result, it builds up in some cells of your immune system. This can lead to an enlarged liver and spleen, changes in the blood, and effects on the bones.

The usual treatment for type 1 Gaucher disease is enzyme replacement therapy (ERT). Miglustat Gen.Orph will only be used in cases where enzyme replacement therapy is not suitable for the patient.

  • Miglustat Gen.Orph is also used to treat the progressive neurological symptoms of Niemann-Pick disease type C in adults and children.

If you have Niemann-Pick disease type C, lipids such as glucosylceramide can build up in the cells of your brain. This can lead to problems with neurological functions such as slow eye movements, balance, swallowing, memory, or seizures.

Miglustat Gen.Orph works by inhibiting the enzyme called glucosylceramide synthase, which is responsible for the first step in the synthesis of most glycosphingolipids.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Miglustat Gen.Orph

Do not take Miglustat Gen.Orph

  • if you are allergic to miglustat or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before you start taking Miglustat Gen.Orph

  • if you have kidney disease
  • if you have liver disease

Your doctor will perform the following tests before and during your treatment with Miglustat Gen.Orph:

  • physical examination of the nerves in your arms and legs
  • measurement of vitamin B12 levels
  • monitoring of growth in children or adolescents with Niemann-Pick disease type C
  • monitoring of platelet count in blood

These tests are necessary because some patients have reported symptoms such as tingling or numbness in hands and feet, or a reduction in body weight during treatment with Miglustat Gen.Orph. The tests will help your doctor determine if these effects are due to your disease or to pre-existing conditions or are side effects of Miglustat Gen.Orph (see section 4 for more details).

If you have diarrhea, your doctor may ask you to modify your diet to reduce lactose and carbohydrate intake, such as sucrose (cane sugar), or not to take Miglustat Gen.Orph with food, or to temporarily reduce the dose. In some cases, your doctor may prescribe medications to treat diarrhea, such as loperamide. Talk to your doctor if the diarrhea does not respond to these measures or if you experience any other abdominal discomfort. In this case, your doctor may decide to perform additional tests.

Male patients are advised to use reliable contraceptive methods during treatment with Miglustat Gen.Orph and for three months after stopping treatment.

Children and adolescents

Do not give this medicine to children and adolescents (under 18 years of age) with type 1 Gaucher disease because it is not known if it works in this disease.

Using Miglustat Gen.Orph with other medicines

Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.

Tell your doctor if you are taking medicines that contain imiglucerase, which are sometimes used at the same time as Miglustat Gen.Orph. They may decrease the amount of Miglustat Gen.Orph in your body.

Pregnancy, breastfeeding, and fertility

Do not take Miglustat Gen.Orph if you are pregnant or planning to become pregnant. For more information, talk to your doctor or pharmacist. You must use an effective contraceptive method while taking Miglustat Gen.Orph. Do not breastfeed while taking Miglustat Gen.Orph.

Male patients must use a reliable contraceptive method during treatment with Miglustat Gen.Orph and for three months after stopping treatment.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, talk to your doctor or pharmacist before using this medicine.

Driving and using machines

Miglustat Gen.Orph may cause dizziness. Do not drive or use tools or machines if you feel dizzy.

3. How to take Miglustat Gen.Orph

Always take this medicine exactly as your doctor has told you.

If you are not sure, talk to your doctor or pharmacist.

  • For type 1 Gaucher disease:In adults, the usual dose is one capsule (100 mg) three times a day (morning, afternoon, evening), which is a maximum daily dose of three capsules (300 mg).

For Niemann-Pick disease type C:In adults and adolescents (over 12 years of age), the usual dose is two capsules (200 mg) three times a day (morning, afternoon, and evening). This is a maximum daily dose of six capsules (600 mg).

For children under 12 years of age, your doctor will adjust the dose for Niemann-Pick disease type C.

In case of kidney problems, your doctor may prescribe a lower initial dose. It is possible that your doctor may reduce the dose of Miglustat Gen.Orph to one capsule (100 mg) one or two times a day if you experience diarrhea during treatment with Miglustat Gen.Orph (see section 4). Your doctor will tell you how long to take the treatment.

Miglustat Gen.Orph can be taken with or without food. Swallow the capsule whole with a glass of water.

If you take more Miglustat Gen.Orph than you should

If you take more capsules than you should, talk to your doctor immediately. In clinical trials, miglustat has been used at doses ten times higher than the recommended dose: this caused a reduction in blood leukocytes and other side effects similar to those described in section 4.

If you forget to take Miglustat Gen.Orph

Take the next capsule when it is due. Do not take a double dose to make up for forgotten doses.

If you stop taking Miglustat Gen.Orph

Do not stop taking Miglustat Gen.Orph without talking to your doctor.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

More serious side effects:

Some patients have reported tingling or numbness in hands and feet (this is a common side effect).These could be signs of peripheral neuropathy, due to side effects of Miglustat Gen.Orph or could be due to pre-existing conditions. Your doctor will perform tests before and during treatment with Miglustat Gen.Orph to assess your case (see section 2).

If you experience any of these side effects, tell your doctor as soon as possible.

If you experiencea mild tremor, usually tremor in the hands, tellyour doctor as soon as possible. The tremor usually resolves without needing to stop treatment. In some cases, your doctor may need to reduce the dose and even stop treatment with Miglustat Gen.Orph to control the tremor.

Very commonmay affect more than 1 in 10 people

Among the most common side effects are diarrhea, flatulence (gas), abdominal pain (stomach), weight loss, and decreased appetite.

If you lose some weightwhen you start taking Miglustat Gen.Orph, do not worry, people usually stop losing weight with continued treatment.

Commonmay affect up to 1 in 10 people

Common side effects are headache, dizziness, paresthesia (tingling or numbness), coordination problems, hypoesthesia (reduced sensation to touch), dyspepsia (heartburn), nausea (feeling sick), constipation, and vomiting, abdominal swelling or discomfort (stomach) and thrombocytopenia (decreased blood platelet levels). Neurological symptoms and thrombocytopenia may be due to the underlying disease.

Other possible side effectsare muscle spasms or weakness, fatigue, chills, and feeling unwell, difficulty sleeping, memory problems, and decreased libido.

Most patients notice one or more side effects of this type, usually when starting treatment or at different times during treatment. Most are mild and resolve quickly. If any of these side effects bother you, talk to your doctor. He or she may reduce the dose of Miglustat Gen.Orph or prescribe other medicines to control the side effects.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Miglustat Gen.Orph

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after “EXP”. The expiry date refers to the last day of the month shown.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

Composition of Miglustat Gen.Orph

The active substanceis miglustat 100 mg.

The other ingredients aresodium starch glycolate (type A),

povidone (K30)

magnesium stearate

gelatin,

titanium dioxide

Appearance of the product and pack size

Miglustat Gen.Orph 100 mg hard capsules are hard gelatin capsules, white in color, with the cap and body opaque, size 4, and approximately 14.0 mm in length.

Box of 12 blisters, each blister containing 7 capsules, for a total of 84 capsules.

Marketing authorization holder:

Gen.Orph

185 Bureaux de la Colline

92213 Saint Cloud Cedex

France

Manufacturer:

Delpharm Reims

10 rue Colonel Charbonneaux

51100 Reims

France

You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder.

Belgium/Belgique/Belgien

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail:

[email protected]

Lithuania

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Bulgaria

??????? ???

???.: +359 2 807 50 00

?-mail: [email protected]

Luxembourg/Luxemburg

Gen.Orph

Tel: +33 (0)1 47 71 04 50

email: [email protected]

Czech Republic

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Hungary

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Denmark

Gen.Orph

Tlf: +46 (0)8 21 54 45

e-mail:

[email protected]

Malta

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Germany

Gen.Orph

Tel: +49 30 8560687897

email:

[email protected]

Netherlands

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Estonia

Gen.Orph

Tel: +33 (0)1 47 71 04 50

email: [email protected]

Norway

Gen.Orph

Tlf: +46 (0)8 21 54 45

e-mail:

[email protected]

Greece

Gen.Orph

Τηλ: +33 (0)1 47 71 04 50

email: [email protected]

Austria

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Spain

Pharma International S.A.

Tel: +34 915 635 856

e-mail: [email protected]

Poland

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

France

Gen.Orph

Tél: +33 (0)1 47 71 04 50

e-mail: [email protected]

Portugal

PharSolution Pharmaceutical Consulting, Lda.

Tel: +351 21 464 32 25

e-mail: [email protected]

Croatia

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Romania

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Ireland

Gen.Orph

Tel: +33 (0)1 47 71 04 50

email: [email protected]

Slovenia

Gen.Orph

Tel: +33 (0)1 47 71 04 50

email: [email protected]

Iceland

Gen.Orph

Sími: +33 (0)1 47 71 04 50

e-mail: [email protected]

Slovakia

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Italy

Biovalley Investments Partner S.r.l.

Tel: +39 040 899 2219

e.mail: [email protected]

Finland

Gen.Orph

Puh/Tel:

+46 (0)8 21 54 45

e-mail: [email protected]

Cyprus

Gen.Orph

Τηλ: +33 (0)1 47 71 04 50

email: [email protected]

Sweden

Gen.Orph

Tel: +46 (0)8 21 54 45

e-mail: [email protected]

Latvia

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

United Kingdom

Gen.Orph

Tel: +33 (0)1 47 71 04 50

e-mail: [email protected]

Date of last revision of this leaflet: {month YYYY}.

Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.

Online doctors for MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES

Discuss questions about MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (77)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
0.0 (0)
Doctor

Chikeluo Okeke

General medicine 4 years exp.

Dr Chikeluo Okeke is an internal medicine doctor with extensive international clinical experience. Originally from Nigeria, he has worked across multiple European healthcare systems and currently practises in Sweden. This professional path has given him a strong understanding of different medical approaches and the ability to work effectively with patients from diverse cultural and linguistic backgrounds.

Dr Okeke focuses on general internal medicine and adult primary care, combining clinical accuracy with careful attention to lifestyle, personal context, and everyday health concerns. His consultations are particularly well suited for people who seek medical advice online, live abroad, or need clear guidance without unnecessary complexity.

He provides online consultations covering symptom assessment, prevention, and long-term management of chronic conditions, helping patients understand what is happening and decide on appropriate next steps.

Common reasons for consultation:

  • General internal medicine concerns and initial health assessment.
  • Acute symptoms such as fever, cough, infections, pain, or weakness.
  • Chronic conditions and treatment adjustment.
  • Blood pressure issues, fatigue, metabolic concerns.
  • Preventive consultations and routine check-ups.
  • Interpretation of laboratory results and medical reports.
  • Medical advice for patients receiving care online.

Dr Okeke is known for his clear communication, calm approach, and cultural awareness. He listens carefully, explains medical decisions in a structured way, and supports patients in making informed choices about their health.

Online consultations with Dr Chikeluo Okeke offer reliable internal medicine care without geographic limitations, focused on medical relevance, clarity, and patient comfort.

Camera Book a video appointment
€60
5.0 (145)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (76)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58

Frequently Asked Questions

Is a prescription required for MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES?
MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES?
The active ingredient in MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES is miglustat. This information helps identify medicines with the same composition but different brand names.
Who manufactures MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES?
MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES is manufactured by Gen.Orph S.A.S.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to MIGLUSTAT GEN.ORPH 100 mg HARD CAPSULES?
Other medicines with the same active substance (miglustat) include MIGLUSTAT ACCORD 100 mg HARD CAPSULES, MIGLUSTAT DIPHARMA 100 mg HARD CAPSULES, OPFOLDA 65 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media